603590 康辰药业
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额82,117199,354119,69070,91358,406
投资活动产生之现金流量净额(28,379)(447,715)(324,507)(642,447)(420,835)
筹资活动产生之现金流量净额(1,670)143,621(56,892)57,756(93,045)
汇率变动对现金及现金等价物的影响(1,955)(1,367)(752)(154)-0
现金及现金等价物净增加/(减少)50,113(106,108)(262,461)(513,932)(455,474)
期初现金及现金等价物余额227,221333,328595,7891,109,7221,565,196
期末现金及现金等价物余额277,333227,221333,328595,7891,109,722